<!DOCTYPE html><html lang="no"><head><title>Forskrift om endring i forskrift om narkotika (narkotikaforskriften)</title><base href="https://lovdata.no/" /></head><body><header class="documentHeader" id="hode"><dl class="data-document-key-info"><dt class="legacyID">Datokode</dt><dd class="legacyID">FOR-2013-12-02-1462</dd><dt class="dokid">DokumentID</dt><dd class="dokid">LTI/forskrift/2013-12-02-1462</dd><dt class="ministry">Departement</dt><dd class="ministry"><ul><li>Helse- og omsorgsdepartementet</li></ul></dd><dt class="publishedIn">Publisert i</dt><dd class="publishedIn">I 2013 hefte 17 s 2973</dd><dt class="dateInForce">I kraft fra</dt><dd class="dateInForce">2013-12-02</dd><dt class="changesToDocuments">Endrer</dt><dd class="changesToDocuments"><ul><li>forskrift/2013-02-14-199</li></ul></dd><dt class="appliesTo">Gjelder for</dt><dd class="appliesTo">Norge</dd><dt class="basedOn">Hjemmel</dt><dd class="basedOn"><ul><li>forskrift/2013-02-14-199/§4</li><li>lov/1992-12-04-132/§22</li><li>forskrift/2013-03-05-1461</li></ul></dd><dt class="dateOfPublication">Kunngjort</dt><dd class="dateOfPublication">2013-12-17 15:20</dd><dt class="journalNumber">Journalnummer</dt><dd class="journalNumber">2013-1213</dd><dt class="titleShort">Korttittel</dt><dd class="titleShort">Endr. i narkotikaforskriften</dd><dt class="title">Tittel</dt><dd class="title">Forskrift om endring i forskrift om narkotika (narkotikaforskriften)</dd><dt class="miscInformation">Annet om dokumentet</dt><dd class="miscInformation"><strong>Hjemmel:</strong> Fastsatt av Statens legemiddelverk 2. desember 2013 med hjemmel i forskrift 14. februar 2013 nr. 199 om narkotika § 4, jf. lov 4. desember 1992 nr. 132 om legemidler m.v. (legemiddelloven) § 22 og delegeringsvedtak 5. mars 2013 nr. 1461.</dd><dt class="refid">RefID</dt><dd class="refid">forskrift/2013-12-02-1462</dd><dt class="table-of-contents">Innhold</dt><dd class="table-of-contents"><ul class="tocTopUl"><li>Forskrift om endring i forskrift om narkotika (narkotikaforskriften)<ul class="tocSubUl"><li>I</li><li></li></ul></li></ul></dd></dl></header><main class="documentBody" data-lovdata-URL="LTI/forskrift/2013-12-02-1462" id="dokument"><h1>Forskrift om endring i forskrift om narkotika (narkotikaforskriften)</h1><section class="section" data-name="kapI" id="kapittel-1" data-lovdata-URL="LTI/forskrift/2013-12-02-1462/KAPITTEL_1"><h2 data-text-align="center">I</h2><article class="legalP" id="kapittel-1-ledd-1">I forskrift 14. februar 2013 nr. 199 om narkotika (narkotikaforskriften) gjøres følgende endringer:</article> <article class="defaultP" margin-top="true">I narkotikalisten tilføyes følgende nye betegnelse og nytt stoff. <table><thead><tr><th data-text-align="center" data-vertical-align="top"><i>Stoffnavn</i></th><th data-text-align="center" data-vertical-align="top"><i>Internasjonal regulering</i></th><th data-text-align="center" data-vertical-align="top"><i>Forbudt etter § 5</i></th><th data-text-align="center" data-vertical-align="top"><i>Unntak og spesielle bestemmelser</i></th></tr></thead><tbody><tr><td data-text-align="left" data-vertical-align="top">Butylon; se bk-MBDB</td><td data-text-align="left" data-vertical-align="top" /><td data-text-align="left" data-vertical-align="top" /><td data-text-align="left" data-vertical-align="top" /></tr><tr><td data-text-align="left" data-vertical-align="top">Lisdexamfetaminum</td><td data-text-align="left" data-vertical-align="top" /><td data-text-align="left" data-vertical-align="top">Forbudt etter § 5</td><td data-text-align="left" data-vertical-align="top">Tillatelse til rekvirering, se § 5</td></tr></tbody></table></article> <article class="defaultP" margin-top="true">Følgende tabell over kjemiske betegnelser erstatter nåværende tabell i forskriften, dette for å rette opp nomenklaturen i tabellen.</article> <article class="defaultP" margin-top="true"><i>Kjemiske betegnelser:</i><table><tbody><tr><td data-text-align="left" data-vertical-align="top">2C-B</td><td data-text-align="left" data-vertical-align="top">2,5-dimetoksy-4-bromfenetylamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">4-MTA</td><td data-text-align="left" data-vertical-align="top">4-metyltioamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">AM-2201</td><td data-text-align="left" data-vertical-align="top">(1-(5-fluorpentyl)-1H-indol-3-yl)(naftalen-1-yl)metanon</td></tr><tr><td data-text-align="left" data-vertical-align="top">Amineptin</td><td data-text-align="left" data-vertical-align="top">7-((10,11-dihydro-5H-dibenzo[a,d]-syklohepten-5-yl)amino)heptansyre</td></tr><tr><td data-text-align="left" data-vertical-align="top">bk-MBDB</td><td data-text-align="left" data-vertical-align="top">β-keto-metylbenzodioksolylbutanamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">DET</td><td data-text-align="left" data-vertical-align="top">N,N-dietyltryptamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">DMA</td><td data-text-align="left" data-vertical-align="top">2,5-dimetoksyamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">DMHP</td><td data-text-align="left" data-vertical-align="top">dimetylheptylpyran</td></tr><tr><td data-text-align="left" data-vertical-align="top">DMT</td><td data-text-align="left" data-vertical-align="top">N,N-dimetyltryptamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">DOB</td><td data-text-align="left" data-vertical-align="top">2,5-dimetoksy-4-bromamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">DOET</td><td data-text-align="left" data-vertical-align="top">2,5-dimetoksy-4-etylamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">DOM/STP</td><td data-text-align="left" data-vertical-align="top">2,5-dimetoksy-4-metylamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">GHB</td><td data-text-align="left" data-vertical-align="top">γ-hydroksybutyrat</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-018</td><td data-text-align="left" data-vertical-align="top">naftalen-1-yl(1-pentyl-1H-indol-3-yl)metanon</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-073</td><td data-text-align="left" data-vertical-align="top">(1-butyl-1H-indol-3-yl)(naftalen-1-yl)metanon</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-081</td><td data-text-align="left" data-vertical-align="top">(4-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-122</td><td data-text-align="left" data-vertical-align="top">(4-metylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-203</td><td data-text-align="left" data-vertical-align="top">2-(2-klorfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-210</td><td data-text-align="left" data-vertical-align="top">(4-etylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon</td></tr><tr><td data-text-align="left" data-vertical-align="top">JWH-250</td><td data-text-align="left" data-vertical-align="top">2-(2-metoksyfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on</td></tr><tr><td data-text-align="left" data-vertical-align="top">MBDB</td><td data-text-align="left" data-vertical-align="top">metylbenzodioksolylbutanamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">MDA</td><td data-text-align="left" data-vertical-align="top">3,4-metylendioksyamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">MDMA</td><td data-text-align="left" data-vertical-align="top">3,4-metylendioksymetamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">MMDA</td><td data-text-align="left" data-vertical-align="top">5-metoksy-3,4-metylendioksyamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">PCE</td><td data-text-align="left" data-vertical-align="top">N-etyl-1-fenylsykloheksanamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">PCPY/PHP</td><td data-text-align="left" data-vertical-align="top">1-(1-fenylsykloheksyl)pyrrolidin</td></tr><tr><td data-text-align="left" data-vertical-align="top">PMA</td><td data-text-align="left" data-vertical-align="top">para-metoksyamfetamin</td></tr><tr><td data-text-align="left" data-vertical-align="top">TCP</td><td data-text-align="left" data-vertical-align="top">1-(1-(2-tienyl)sykloheksyl)piperidin</td></tr><tr><td data-text-align="left" data-vertical-align="top">TMA</td><td data-text-align="left" data-vertical-align="top">3,4,5-trimetoksyamfetamin</td></tr></tbody></table></article></section><section class="section" id="kapittel-2" data-lovdata-URL="LTI/forskrift/2013-12-02-1462/KAPITTEL_2"><h2 data-text-align="center" /><article class="centeredP" data-text-align="center"><i>Ikrafttredelse</i></article><article class="legalP" id="kapittel-2-ledd-1">Endringene trer i kraft umiddelbart.</article></section></main></body></html>